FDA
-
-
-
-
-
-
-
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split
-
-
-
-
-
-
-
Curis closes $80.8 million private placement led by Nantahala Capital
-
-
-
-
-
-
-
Curis Provides Third Quarter 2025 Business Update
-
-
-
-
-
-
-
Curis (CRIS) Announces $7M Share and Warrant Offering
-
-
-
-
-
-
-
Curis (CRIS) Provides Q4 Business Update
-
-
-
-
-
-
-
Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024
-
-
-
-
-
-
-
Curis Provides Second Quarter 2024 Financial and Operating Update
-
327,204 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

